Molecular genetics and genomics of heart failure

Choong-Chin Liew1, Victor J Dzau

  • 1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Louis Pasteur Avenue, NRB room 0630K, Boston, Massachusetts 02115, USA. cliew@rics.bwh.harvard.edu

Nature Reviews. Genetics
|November 3, 2004
PubMed

Insights

Heart failure is a growing global health challenge. Recent genomic studies are revealing key molecular and genetic factors driving this complex cardiovascular disease.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Heart failure represents a significant and increasing global health burden.
  • Declining mortality from other cardiovascular diseases contributes to a rising incidence of heart failure.
  • The complete molecular understanding of heart failure pathophysiology remains elusive.

Purpose of the Study:

  • To summarize the current knowledge on the molecular and genetic underpinnings of heart failure.
  • To explore the impact of novel genomic tools on understanding heart failure.
  • To provide a comprehensive overview of heart failure's genetic basis.

Main Methods:

  • Review of molecular and genetic studies in heart failure.
  • Analysis of recent advancements in genomic technologies.
  • Synthesis of current literature on heart failure pathophysiology.

Main Results:

  • Identification of various implicated pathways and genes in heart failure development.
  • Demonstration of how genomic tools offer new insights into disease mechanisms.
  • Highlighting the multifactorial nature of heart failure.

Conclusions:

  • Genomic tools are revolutionizing the study of heart failure.
  • A deeper understanding of the molecular and genetic basis is crucial for future treatments.
  • Continued research is essential to fully elucidate heart failure's complex etiology.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...